QA: MyMD Pharmaceuticals Inc. in us_medicinal_products/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001321834_2019_MyMD_Pharmaceuticals_Inc.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.12713293199370598, 'aggregate_val': 7807253, 'exp_sum': 8944378, 'exp_to_value': {'AssetsCurrent': 6670128, 'AssetsNoncurrent': 1137125, 'PropertyPlantAndEquipmentNet': 83456, 'Goodwill': 243411, 'remainder_Assets': 810258}}

Graph

Absolute values for 0001321834, MyMD Pharmaceuticals Inc.

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 1,973,500
2 remainder_Liabilities 0
3 AssetsCurrent 6,670,128
4 AssetsNoncurrent 1,137,125
5 PropertyPlantAndEquipmentNet 83,456
6 Goodwill 243,411
7 remainder_Assets -326,867
8 GeneralAndAdministrativeExpense 8,986,618
9 ResearchAndDevelopmentExpense 1,063,253
10 remainder_Expenses 1,676,108
11 remainder_Revenues 1,665,570
12 remainder_NetIncome 788,625
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 1,973,500
1 Assets 7,807,253
2 Expenses 11,725,979
3 Revenues 1,665,570
4 StockholdersEquity 5,833,753
5 NetIncome -9,271,784
6 ComprehensiveNetIncome -9,271,784
7 BaseVar 11,980,464
8 EconomicCapitalRatio -0.882

Edgar->Model Mapping

Feature Distribution

Change over Time